| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For ABUS | |||||
| 2025-08-04 | Sawhney, Roger | Director | Purchased | 157600 | $0.00 |
| 2025-03-31 | Nguyen, Tuan | Chief Financial Officer | Purchased | 750000 | $0.00 |
| 2025-03-18 | Hasija, Anuj | Director | Purchased | 157600 | $0.00 |
| 2025-03-18 | Beardsley, Robert A | Director | Purchased | 157600 | $0.00 |
| 2025-03-18 | Androski, Lindsay | Director, President and CEO | Purchased | 310422 | $0.00 |
| 2025-02-14 | Sims, Karen | Chief Medical Officer | Purchased | 200300 | $0.00 |
| 2025-02-14 | Naftzger, J. Christopher | General Counsel and CCO | Purchased | 54300 | $0.00 |
| 2025-02-14 | Naftzger, J. Christopher | General Counsel and CCO | Purchased | 220300 | $0.00 |
| 2025-02-14 | Mcelhaugh, Michael J. | Director, Interim President & CEO | Purchased | 177000 | $0.00 |
| 2025-02-14 | Mcelhaugh, Michael J. | Director, Interim President & CEO | Purchased | 718800 | $0.00 |
| 2025-02-14 | Hastings, David C | Chief Financial Officer | Purchased | 90100 | $0.00 |
| 2025-02-14 | Hastings, David C | Chief Financial Officer | Purchased | 365800 | $0.00 |
| 2025-02-14 | Sims, Karen | Chief Medical Officer | Purchased | 49300 | $0.00 |
| 2025-02-04 | Hastings, David C | Chief Financial Officer | Sold | 22183 | $3.28 |
| 2025-02-04 | Mcelhaugh, Michael J. | Director, Interim President & CEO | Sold | 23790 | $3.28 |
| 2025-02-04 | Naftzger, J. Christopher | General Counsel and CCO | Sold | 11333 | $3.28 |
| 2025-02-04 | Sims, Karen | Chief Medical Officer | Sold | 19348 | $3.28 |
| 2024-08-14 | Manchester, Keith S | Director | Sold | 54915 | $0.00 |
| 2024-08-14 | Manchester, Keith S | Director | Purchased | 54915 | $0.56 |
| 2024-08-14 | Manchester, Keith S | Director | Sold | 8846 | $3.69 |
